Oxford Vaccine
-
{
- All
- News
- Videos
-
3-Month Gap Between Oxford Vaccine Jabs Gives Better Efficacy: Study
A three-month interval between doses of the Oxford COVID-19 vaccine results in higher vaccine efficacy than a six-week gap, according to a new study which says the first dose can offer up to 76 per cent protection in the months between the two jabs.
-
Does World Need New Covid Vaccines? Oxford Vaccine Trial Chief Said This
It is not yet clear whether or not the world needs a new set of vaccines to fight different variants of the novel coronavirus but scientists are working on new ones so there is no reason for alarm, the head of the Oxford Vaccine Group said on Tuesday.
-
Oxford Vaccine Gives Good Immune Responses In Elderly, Says Trial Chief
The COVID-19 vaccine developed by Oxford University and AstraZeneca gives good immune responses in older people, even if there is a lack of data about its exact efficacy, Oxford's vaccine trial chief Andrew Pollard said on Wednesday.
-
Covid Vaccines May Provide Protection Even As Variants Evolve: Oxford
COVID-19 vaccines might offer protection against severe disease even as coronavirus variants evolve to better allow continued transmission between people, the head of the Oxford Vaccine Group Andrew Pollard said on Wednesday.
-
Oxford Kept UK Vaccine Volunteers In Dark On Dose Error: Report
About 1,500 of the initial volunteers in a late-stage clinical trial of the Oxford/AstraZeneca COVID-19 vaccine were given the wrong dose, but weren't informed that a mistake had been made after the blunder was discovered, documents obtained by Reuters show.
-
Bolivia, Serum Institute Sign Deal For 5 Million Oxford Vaccine Doses
The Bolivian government said on Wednesday it had signed a contract with Serum Institute for the supply of 5 million doses of AstraZeneca's COVID-19 vaccine.
-
Oxford COVID-19 Vaccine Cleared By Expert Panel For India
The Oxford COVID-19 vaccine manufactured by the Serum Institute of India will be sent for approval to the regulator Drugs Controller General of India (DCGI) by a government-appointed panel of experts.
-
US Expects To Approve UK-Backed AstraZeneca-Oxford Vaccine In April
The United States is expected to approve the low-cost AstraZeneca/Oxford vaccine in April, a senior official said, more than three months after Britain's green light on Wednesday.
-
UK Medicine Regulator To Assess Best Dose For Oxford COVID-19 Vaccine
Britain's medical regulator will examine all the data from trials of the COVID-19 vaccine developed by Oxford and AstraZeneca, including which dosing regimen is best to use, the regulator's chief executive said on Wednesday.
-
Oxford Vaccine Better At Stopping Covid Than Slowing Spread: Report
A vaccine from the University of Oxford and AstraZeneca Plc shows only a limited ability to stop transmission of the coronavirus despite preventing Covid-19 illness in a majority of those who are infected.
-
Oxford Vaccine Effective But Questions On Those Above 55: Report
On the day Britain began immunizing its population with a Covid-19 shot developed by Germany's BioNTech SE and the U.S.'s Pfizer Inc., a peer-reviewed study of the U.K.'s homegrown vaccine left some key questions unanswered.
-
Pfizer, Oxford Vaccines To Be Tested Together In UK Combination Trials
Even as it begins the first Covid immunizations with a shot from Pfizer Inc., the U.K. plans to test it in combination with another vaccine from AstraZeneca Plc.
-
Centre Rejects Volunteer's Claim, Clears Oxford Vaccine Trials In India
The government today said it had found no reason to stop the Oxford vaccine trials in India after reviewing a Chennai volunteer's allegation of serious adverse effects, including memory loss and change in behavior.
-
"He Lost Ability To Do Simple Tasks": Vaccine Volunteer's Wife To NDTV
A Chennai volunteer whose allegations of adverse effects from the Oxford vaccine trials have led to a 100-crore lawsuit by Serum Institute of India (SII), lost an American job and has found it difficult to do even simple tasks, his wife has said.
-
Oxford Covid Vaccine Safe, Says Serum Institute After AstraZeneca Admits Error
Vaccine major Serum Institute of India on Thursday said the COVID-19 vaccine developed by AstraZeneca and Oxford University is safe and effective, and the Indian trials are progressing smoothly with strict adherence to all protocols.
-
3-Month Gap Between Oxford Vaccine Jabs Gives Better Efficacy: Study
A three-month interval between doses of the Oxford COVID-19 vaccine results in higher vaccine efficacy than a six-week gap, according to a new study which says the first dose can offer up to 76 per cent protection in the months between the two jabs.
-
Does World Need New Covid Vaccines? Oxford Vaccine Trial Chief Said This
It is not yet clear whether or not the world needs a new set of vaccines to fight different variants of the novel coronavirus but scientists are working on new ones so there is no reason for alarm, the head of the Oxford Vaccine Group said on Tuesday.
-
Oxford Vaccine Gives Good Immune Responses In Elderly, Says Trial Chief
The COVID-19 vaccine developed by Oxford University and AstraZeneca gives good immune responses in older people, even if there is a lack of data about its exact efficacy, Oxford's vaccine trial chief Andrew Pollard said on Wednesday.
-
Covid Vaccines May Provide Protection Even As Variants Evolve: Oxford
COVID-19 vaccines might offer protection against severe disease even as coronavirus variants evolve to better allow continued transmission between people, the head of the Oxford Vaccine Group Andrew Pollard said on Wednesday.
-
Oxford Kept UK Vaccine Volunteers In Dark On Dose Error: Report
About 1,500 of the initial volunteers in a late-stage clinical trial of the Oxford/AstraZeneca COVID-19 vaccine were given the wrong dose, but weren't informed that a mistake had been made after the blunder was discovered, documents obtained by Reuters show.
-
Bolivia, Serum Institute Sign Deal For 5 Million Oxford Vaccine Doses
The Bolivian government said on Wednesday it had signed a contract with Serum Institute for the supply of 5 million doses of AstraZeneca's COVID-19 vaccine.
-
Oxford COVID-19 Vaccine Cleared By Expert Panel For India
The Oxford COVID-19 vaccine manufactured by the Serum Institute of India will be sent for approval to the regulator Drugs Controller General of India (DCGI) by a government-appointed panel of experts.
-
US Expects To Approve UK-Backed AstraZeneca-Oxford Vaccine In April
The United States is expected to approve the low-cost AstraZeneca/Oxford vaccine in April, a senior official said, more than three months after Britain's green light on Wednesday.
-
UK Medicine Regulator To Assess Best Dose For Oxford COVID-19 Vaccine
Britain's medical regulator will examine all the data from trials of the COVID-19 vaccine developed by Oxford and AstraZeneca, including which dosing regimen is best to use, the regulator's chief executive said on Wednesday.
-
Oxford Vaccine Better At Stopping Covid Than Slowing Spread: Report
A vaccine from the University of Oxford and AstraZeneca Plc shows only a limited ability to stop transmission of the coronavirus despite preventing Covid-19 illness in a majority of those who are infected.
-
Oxford Vaccine Effective But Questions On Those Above 55: Report
On the day Britain began immunizing its population with a Covid-19 shot developed by Germany's BioNTech SE and the U.S.'s Pfizer Inc., a peer-reviewed study of the U.K.'s homegrown vaccine left some key questions unanswered.
-
Pfizer, Oxford Vaccines To Be Tested Together In UK Combination Trials
Even as it begins the first Covid immunizations with a shot from Pfizer Inc., the U.K. plans to test it in combination with another vaccine from AstraZeneca Plc.
-
Centre Rejects Volunteer's Claim, Clears Oxford Vaccine Trials In India
The government today said it had found no reason to stop the Oxford vaccine trials in India after reviewing a Chennai volunteer's allegation of serious adverse effects, including memory loss and change in behavior.
-
"He Lost Ability To Do Simple Tasks": Vaccine Volunteer's Wife To NDTV
A Chennai volunteer whose allegations of adverse effects from the Oxford vaccine trials have led to a 100-crore lawsuit by Serum Institute of India (SII), lost an American job and has found it difficult to do even simple tasks, his wife has said.
-
Oxford Covid Vaccine Safe, Says Serum Institute After AstraZeneca Admits Error
Vaccine major Serum Institute of India on Thursday said the COVID-19 vaccine developed by AstraZeneca and Oxford University is safe and effective, and the Indian trials are progressing smoothly with strict adherence to all protocols.
